Transcriptomic analysis reveals pathways underlying the multi‐antibiotic resistance of Klebsiella pneumoniae
IET Systems Biology · 2025
DOI: 10.1049/syb2.12112 ↗Kurz gefasst
Fachartikel in der Zeitschrift IET Systems Biology, 2025. Verfasst von Ying Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Gene Expression Profiling, Drug Resistance, Multiple, Bacterial, Transcriptome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Corporate Partnership Program, Suzhou Municipal Basic Research Special Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Klebsiella pneumoniae, an opportunistic pathogen, is pervasively distributed across the world. Its escalating antibiotic resistance poses a serious threat to global public health. The mechanisms behind this resistance remain largely elusive. In this study, we performed antibiotic susceptibility testing on several clinical isolates of Klebsiella pneumoniae , and a reference strain ATCC13883, and then analysed their transcriptomic profiles to identify genes and pathways associated with antibiotic resistance. Our results showed that a clinical isolate DY16KPN may counteract antibiotics by enhancing the biosynthesis of building blocks of bacterial cell, such as fatty acids, proteins, and DNA, and reducing transmembrane transport. Increased butanoate metabolism and lipopolysaccharide biosynthesis may also contribute to the drug‐resistance of Klebsiella pneumoniae . Additionally, we identified resistance‐promoting mutations in gene promoter regions, which regulate the activity of downstream drug‐resistant genes and pathways. Our results also demonstrated that DY16KPN counterbalances the trimethoprim/sulfamethoxazole‐mediated inhibitory effect on the synthesis of tetrahydrofolates and DNA by up‐regulating the expression of targeted enzymes of trimethoprim/sulfamethoxazole, dihydrofolate reductase and dihydropteroate synthase.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Thoracic Surgery, The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, China.
- School of Life Science and Technology, Inner Mongolia University of Science and Technology, Baotou, China.
- Pharmaceutical Laboratory, Inner Mongolia International Mongolian Hospital, Hohhot, China.
ORCID-Profile: Guoqing Liu
Förderung
- Corporate Partnership Program
- Suzhou Municipal Basic Research Special Project
- National Natural Science Foundation of China
- Fundamental Research Funds for Inner Mongolia University of Science and Technology
- Innovation Support Program for Overseas Returnees of Inner Mongolia Autonomous Region
Zitieren
APA
Liu, Y., Niu, Z., Wu, R., Yang, D., Chen, J., Liu, G., & Zhao, J. (2025). Transcriptomic analysis reveals pathways underlying the multi‐antibiotic resistance of Klebsiella pneumoniae. IET Systems Biology. https://doi.org/10.1049/syb2.12112
Vancouver
Liu Y, Niu Z, Wu R, Yang D, Chen J, Liu G, et al. Transcriptomic analysis reveals pathways underlying the multi‐antibiotic resistance of Klebsiella pneumoniae. IET Systems Biology. 2025. doi:10.1049/syb2.12112
BibTeX
@article{Liu2025,
author = {Liu, Ying and Niu, Zhihui and Wu, Rile and Yang, Dezhi and Chen, Jun and Liu, Guoqing and Zhao, Jun},
title = {Transcriptomic analysis reveals pathways underlying the multi‐antibiotic resistance of Klebsiella pneumoniae},
journal = {IET Systems Biology},
year = {2025},
doi = {10.1049/syb2.12112}
}
EUVIMED